News
AGC to Expand Synthetic Pharmaceutical Production Base in Spain
AGC Inc., a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand the facilities of AGC Pharma Chemicals Europe S.L.U. (hereinafter...
Press Releases
SciRhom starts CMC development of its first drug candidate for clinical development
SciRhom GmbH announced today that it has nominated the anti-iRhom2 antibody it will advance into clinical development. For this antibody, the company has closed...
News
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries
ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for advanced therapies,...
Press Releases
BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines
BioNTech SE and Matinas BioPharma, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid...
News
Tjoapack expands into the US with the acquisition of Pharma Packaging Solutions
Tjoapack, a contract packaging organisation serving the pharmaceutical industry, has acquired US-based Pharma Packaging Solutions (PPS), a leading healthcare packaging services business based in...
News
Clinical Development Organizations Primary Success Factors
Executive leaders at pharma and biotech companies are realising that an initial investment in a clinical trial associate's (CTA) career can impact and build...
News
NICE Urges Gilead Reduce Trodelvy Price, Bans Eczema Drugs
The United Kingdom's drug price watchdog had a bad week. The National Institute of Health and Care Excellence has denied Gilead Sciences' Trodelvy for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















